Development of Biological Diversity and Susceptibility to Chemotherapy in Murine Cancer Metastases

James E Talmadge, Karen Benedict, John Madsen, Isaiah J. Fidler

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

We studied the development of biological heterogeneity in a spontaneous melanoma metastasis of clonal origin as demonstrated by karyotypic analysis. The metastatic potential and sensitivity to different chemotherapeutic agents varied both among and within clones of this metastasis isolated either in vitro or in vivo. This finding indicates that, even within a metastasis of clonal origin, cellular heterogeneity for chemotherapy or metastatic potential can develop rapidly and provides a mechanism for the emergence of resistance to therapy. Since most cancer deaths result from metastases that do not respond to treatment, the implications of these findings for the treatment of cancer are clear. Treatment modalities must be designed that circumvent the biological heterogeneity that can develop rapidly within each metastasis and among metastases.

Original languageEnglish (US)
Pages (from-to)3801-3805
Number of pages5
JournalCancer Research
Volume44
Issue number9
StatePublished - Sep 1 1984

Fingerprint

Biodiversity
Neoplasm Metastasis
Drug Therapy
Neoplasms
Therapeutics
Melanoma
Clone Cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Development of Biological Diversity and Susceptibility to Chemotherapy in Murine Cancer Metastases. / Talmadge, James E; Benedict, Karen; Madsen, John; Fidler, Isaiah J.

In: Cancer Research, Vol. 44, No. 9, 01.09.1984, p. 3801-3805.

Research output: Contribution to journalArticle

Talmadge, James E ; Benedict, Karen ; Madsen, John ; Fidler, Isaiah J. / Development of Biological Diversity and Susceptibility to Chemotherapy in Murine Cancer Metastases. In: Cancer Research. 1984 ; Vol. 44, No. 9. pp. 3801-3805.
@article{f3a94c1c96324ca3b8dd21d615ab1e55,
title = "Development of Biological Diversity and Susceptibility to Chemotherapy in Murine Cancer Metastases",
abstract = "We studied the development of biological heterogeneity in a spontaneous melanoma metastasis of clonal origin as demonstrated by karyotypic analysis. The metastatic potential and sensitivity to different chemotherapeutic agents varied both among and within clones of this metastasis isolated either in vitro or in vivo. This finding indicates that, even within a metastasis of clonal origin, cellular heterogeneity for chemotherapy or metastatic potential can develop rapidly and provides a mechanism for the emergence of resistance to therapy. Since most cancer deaths result from metastases that do not respond to treatment, the implications of these findings for the treatment of cancer are clear. Treatment modalities must be designed that circumvent the biological heterogeneity that can develop rapidly within each metastasis and among metastases.",
author = "Talmadge, {James E} and Karen Benedict and John Madsen and Fidler, {Isaiah J.}",
year = "1984",
month = "9",
day = "1",
language = "English (US)",
volume = "44",
pages = "3801--3805",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Development of Biological Diversity and Susceptibility to Chemotherapy in Murine Cancer Metastases

AU - Talmadge, James E

AU - Benedict, Karen

AU - Madsen, John

AU - Fidler, Isaiah J.

PY - 1984/9/1

Y1 - 1984/9/1

N2 - We studied the development of biological heterogeneity in a spontaneous melanoma metastasis of clonal origin as demonstrated by karyotypic analysis. The metastatic potential and sensitivity to different chemotherapeutic agents varied both among and within clones of this metastasis isolated either in vitro or in vivo. This finding indicates that, even within a metastasis of clonal origin, cellular heterogeneity for chemotherapy or metastatic potential can develop rapidly and provides a mechanism for the emergence of resistance to therapy. Since most cancer deaths result from metastases that do not respond to treatment, the implications of these findings for the treatment of cancer are clear. Treatment modalities must be designed that circumvent the biological heterogeneity that can develop rapidly within each metastasis and among metastases.

AB - We studied the development of biological heterogeneity in a spontaneous melanoma metastasis of clonal origin as demonstrated by karyotypic analysis. The metastatic potential and sensitivity to different chemotherapeutic agents varied both among and within clones of this metastasis isolated either in vitro or in vivo. This finding indicates that, even within a metastasis of clonal origin, cellular heterogeneity for chemotherapy or metastatic potential can develop rapidly and provides a mechanism for the emergence of resistance to therapy. Since most cancer deaths result from metastases that do not respond to treatment, the implications of these findings for the treatment of cancer are clear. Treatment modalities must be designed that circumvent the biological heterogeneity that can develop rapidly within each metastasis and among metastases.

UR - http://www.scopus.com/inward/record.url?scp=0021129112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021129112&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 3801

EP - 3805

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 9

ER -